Daniel Paul Regan Insider Trading
Get free email notifications about insider trading for Daniel Paul Regan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel Paul Regan. Daniel Paul Regan is a Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and a Chief Commerical Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Address: C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK 10013 NY
Companies in which Daniel Paul Regan is an Insider
INTERCEPT PHARMACEUTICALS, INC.
Trading Symbol: ICPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel Paul Regan: Chief Commerical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 06 2013
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KERYX BIOPHARMACEUTICALS INC
Trading Symbol: KERXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel Paul Regan: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Daniel Paul Regan
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Sell | D | 0.00 | 60,000 | 0 | 0 | 60 K to 0 (-100.00 %) |
Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Grant | A | 0.00 | 10,000 | 0 | 60,000 | 50 K to 60 K (+20.00 %) |
Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Option Exercise | A | 6.56 | 30,000 | 196,800 | 30,000 | |
Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Grant | A | 0.00 | 10,000 | 0 | 50,000 | 40 K to 50 K (+25.00 %) |
May 27 2016 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Option Exercise | A | 5.71 | 30,000 | 171,300 | 30,000 |